Clinical Pearls: Q&A with William F. Young, Jr., MD, Editor-in-Chief of JCEM Case Reports
Extracellular Vesicles Offer New Insights into Treating Endocrine Disorders
Endocrine Society issues Scientific Statement to explain the endocrine roles of extracellular vesicles. In a new Scientific Statement released today, the Endocrine Society describes the importance of extracellular vesicles as a new research target for understanding the causes of certain endocrine disorders such as cancer and diabetes and discovering new treatments for these disorders. During...
Misinformation disregards science and restricts access to evidence-based care. The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care. We call on the Florida Department...
Faeth Therapeutics, a healthcare company developing machine learning-driven precision nutrition solutions and therapeutic regimens to treat cancer, announced the appointment of Endocrine Society member Thomas Strack, MD, as chief medical officer. Strack brings more than 29 years of biopharmaceutical industry and has led all phases of clinical development. Strack previously served as senior vice president,...
Endocrine Society Speaks Out Against Texas Governor’s Anti-Transgender Directive
On Monday, February 21, the Texas attorney general issued a nonbinding legal opinion arguing that gender-affirming care falls under the state’s existing definition of child abuse and neglect. Following this, Texas Governor Greg Abbott released a directive ordering the Texas Department of Family and Protective Services (DFPS) to conduct investigations of any reported instances of...
Dynamic Duo: Talking with the Editors of a New Book on Endocrine Diseases in Pregnancy
Endocrine Society Applauds House for Taking Action to Improve Insulin Affordability
Underlying problem of rising insulin prices still needs to be addressed. The Endocrine Society applauds the House of Representatives for hearing our call to improve insulin affordability for people with diabetes as it prepares to vote on the Affordable Insulin Now Act this week. The bill would cap patients’ out-of-pocket insulin costs to $35 per month for people on Medicare and private...